Age-Related Macular Degeneration Market Research Report by Leading Key Players - Novartis, Roche, Bayer, Regeneron Pharmaceutical, Acucela, GlaxoSmithKline, Alimera Sciences

The global age-related macular degeneration market was valued at $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022.Among the various types, the wet AMD segment is expected to witness the faster growth compared to dry AMD segment, during the forecast period. The global age-related macular degeneration market is growing at a significant rate, due to increasing healthcare cost, and increasing prevalence lifestyle associated diseases, such as obesity and hypertension. In addition, the growing geriatric population, increasing prevalence of AMD and increasing pipeline drugs for AMD are also driving the growth of the global age-related macular degeneration market.

Read this Report: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-market

Age-related macular degeneration (AMD) is an acquired retinal disorder indicated by fundus changes. It is one of the most common forms of visual impairment in the geriatric population. It is a deterioration or degeneration of macular, leading to vision loss among people aged 60 years and above. The macula is a small part of retina responsible for sharpness and central vision.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-market/report-sample

Geographically, North America dominated the global market of age-related macular degeneration in 2015; whereas, the Asia-Pacific market is expected to witness the fastest growth, during the forecast period.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=age-related-macular-degeneration-market

Some of the key companies operating in the global age-related macular degeneration market include Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Regeneron Pharmaceutical, Inc., Acucela, Ophthotech Corporation, Neurotech Pharmaceuticals, Inc., GlaxoSmithKline plc, StemCells Inc and Alimera Sciences, Inc.

GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION
Type
• Wet AMD
• Dry AMD

By Drug
• Lucentis
• Eylea
• Avastin
• Visudyne
• Others

By Geography
• North America
o U.S.
o Rest of North America

• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest of Europe

• Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• Rest of the World (RoW)

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.